Investment Company News

11 May 2018

VinaLand sells Pavilion Square project

VinaLand sells Pavilion Square project – VinaLand Limited has sold its entire stake in the Pavilion Square project. The project, located in Ho Chi Minh City, Vietnam and acquired by VinaLand in 2007, is designated for a future mixed-use development. VinaLand has sold its entire stake in the project to RC12 Investment Joint Stock Company […]

11 May 2018
Harbourvest Global Private Equity US dollar quote

Stronger sterling depresses HarbourVest’s returns

Stronger sterling depresses Harbourvest’s returns – HarbourVest Global Private Equity Limited has reported 16.2% NAV growth to $21.46 from $18.47 over the year to 31 January 2018. 55% of HVPE’s assets consist directly of US investments and a further 23% of assets are denominated in US dollars. In the year to 31 January 2018, sterling […]

11 May 2018

3i Infrastructure’s ‘outstanding’ year

3i Infrastructure’s ‘outstanding’ year – 3i Infrastructure has announced a 28.6% return for the year ended 31 march 2018 and a 10% increase in the target dividend for FY19 to 8.65 pence per share. Richard Laing, its chairman, said: “The company had an outstanding year. The realisations of our holdings in Elenia and Anglian Water Group generated […]

10 May 2018

Prothena drags WPCT to bottom of performance league table in April

Prothena drags WPCT to bottom of performance league table in April The fall in the value of its large investment in Prothena on negative results from two late-stage trials last month had a predictable effect on Woodford Patient Capital (WPCT)’s performance among the biotech-specialist closed end funds this year, although its relative underperformance extends over […]

10 May 2018

HBM set to gain on Lilly buyout of investee Armo

HBM set to gain on Lilly buyout of investee Armo Swiss-listed HBM Healthcare (HBMN) looks set to see a significant boost to its already strong investment performance this year as a result of a deal that will see Eli Lilly buy one of its investee companies, the US biotech ARMO Biosciences.  Lilly’s agreed deal to […]

10 May 2018

Life Settlement Assets announces three ‘maturities’

Life Settlement Assets announces three ‘maturities’ – Life Settlement Assets has made the following announcement: “The company has received notification of three policy maturities on two lives with a face value of USD1,784,882.18 for the benefit of the B share class (LSAB).  These maturities reflect the lumpy nature of returns from the portfolio and are […]

10 May 2018

Shaftesbury makes a strategic acquisition in Carnaby

Shaftesbury makes a strategic acquisition in Carnaby – Shaftesbury (SHB) the Real Estate Investment Trust (REIT) has exchanged contracts to acquire the freehold of 35 and 36 Great Marlborough Street, Carnaby for £22.7 million. Located at the northern gateway in to Carnaby, the buildings comprise two shops (3,000 sq. ft.) with 4,250 sq. ft. of office accommodation on the […]

10 May 2018

HgCapital invests in medical software provider MediFox

HgCapital invests in medical software provider MediFox – HgCapital (HGT) has announced an investment in MediFox, a provider of software solutions to outpatient and inpatient care providers and therapy practices in Germany. The terms of the transaction were not disclosed. The investment for £8.0m follows an exit from private equity funds managed by Equity Capital […]

09 May 2018

Civitas share price boosted as it sorts potential First Priority problem

Civitas share price boosted as it sorts potential First Priority problem – Civitas Social Housing has announced that today, 9 May 2018, all Civitas leases previously with First Priority were assigned, on the same terms to Falcon Housing Association C.I.C, an existing Civitas housing association partner. Civitas’ share price is up 2% on the news. In addition, […]

09 May 2018

Puretech digital health venture raises $55m

Puretech digital health venture raises $55m LSE-listed healthcare venture firm Puretech Health (PRTC)’s digital health offshoot, Akili Interactive, has raised $55m in a series C financing. The move comes ahead of its planned FDA filing for a tablet-based video game for the treatment for attention deficit hyperactivity disorder (ADHD). This product, AKL-T01, would – if approved – become one […]

Please review our cookie, privacy & data protection and terms and conditions policies and, if you accept, please select your place of residence and whether you are a private or professional investor.

You live in…

You are a…